HB 1689 – Washington
Status: EnactedYear Introduced: 2022
Link: https://app.leg.wa.gov/billsummary?BillNumber=1689&Year=2021&Initiative=false
Requires health plans to exempt biomarker testing for cancer or cancer progression or recurrence from prior authorization requirements.
Return to Database Search
© 2018- The SLIHCQ Database. Initial funding for this project was provided by the Robert Wood Johnson Foundation. The views expressed here do not necessarily reflect the views of the Foundation.
Associated Litigation:
No items found